Ocular Application of Nerve Growth Factor Protects Degenerating Retinal Ganglion Cells in a Rat Model of Glaucoma

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of glaucoma

• Publication date

  2011-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/IJG.0b013e3181d787e5PMID 20436364
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glaucoma alters the expression of NGF and NGF receptors in visual cortex and geniculate nucleus of rats: effect of eye NGF application.

  2009cited by this paper
• Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma

  2009cited by this paper
• Reduced NGF level and TrkA protein and TrkA gene expression in the optic nerve of rats with experimentally induced glaucoma.

  2008cited by this paper
• Retinal p75 and bax overexpression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma

  2008cited by this paper
• Neurotrophic rationale in glaucoma: A TrkA agonist, but not NGF or a p75 antagonist, protects retinal ganglion cells in vivo

  2007cited by this paper
• Effects of Nerve Growth Factor for Retinal Cell Survival in Experimental Retinal Detachment

  2007cited by this paper
• Chondroitin sulfate-derived disaccharide protects retinal cells from elevated intraocular pressure in aged and immunocompromised rats.

  2007cited by this paper
• Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: biochemical and structural evidence.

  2007cited by this paper
• Eye drop NGF administration promotes the recovery of chemically injured cholinergic neurons of adult mouse forebrain

  2007cited by this paper
• Lessons for glaucoma from other neurodegenerative diseases: can one treatment suit them all?

  2005cited by this paper
• Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies.

  2005cited by this paper
• Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats.

  2005cited by this paper
• Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa.

  2005cited by this paper
• Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix.

  2005cited by this paper
• Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice

  2004cited by this paper
• NGF and related molecules in health and disease

  2004cited by this paper
• Changes in retinal expression of neurotrophins and neurotrophin receptors induced by ocular hypertension.

  2004cited by this paper
• Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of Type 1 diabetic mice

  2004cited by this paper
• Primary open-angle glaucoma.

  2004cited by this paper
• Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond.

  2003cited by this paper
• In vivo expression of neurotrophins and neurotrophin receptors is conserved in adult porcine retina in vitro.

  2003cited by this paper
• Retinal ganglion cells and neuroprotection for glaucoma.

  2003cited by this paper
• Gene Expression of Neurotrophins and Their High-Affinity Trk Receptors in Cultured Human Müller Cells

  2002cited by this paper
• Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey.

  2001cited by this paper
• Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.

  2001cited by this paper
• Beyond Intraocular Pressure: Neuroprotective Strategies for Future Glaucoma Therapy

  2001cited by this paper
• Diffusion of high molecular weight compounds through sclera.

  2000cited by this paper
• Neurotrophins in cell survival/death decisions.

  1999cited by this paper
• Neurotrophins: the biological paradox of survival factors eliciting apoptosis

  1998cited by this paper
• The role of neuronal growth factors in neurodegenerative disorders of the human brain.

  1998cited by this paper
• Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension

  1997cited by this paper
• A rat model of chronic pressure-induced optic nerve damage.

  1997cited by this paper
• Expression of neurotrophins and Trk receptors in the avian retina

  1996cited by this paper
• Number of people with glaucoma worldwide.

  1996cited by this paper
• Nerve growth factor delays retinal degeneration in C3H mice

  1996cited by this paper
• Nerve growth factor reduces apoptosis of axotomized retinal ganglion cells in the neonatal rat.

  1994cited by this paper
• Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo.

  1993cited by this paper
• Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia.

  1993cited by this paper
• Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light.

  1992cited by this paper
• The nerve growth factor family of receptors.

  1992cited by this paper
• Intraocular pressure and glaucoma.

  1989cited by this paper
• Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section

  1989cited by this paper
• The nerve growth factor 35 years later.

  1987cited by this paper
• The nerve growth factor: purification as a 30,000-molecular-weight protein.

  1969influential reference

• Targeted Neuroprotection of Retinal Ganglion Cells Via AAV2-hSyn-NGF Gene Therapy in Glaucoma Models

  2025cites this paper
• A Comprehensive QbD Study on Bioadhesive Ocular Films for Improved Conjunctivitis Management: Insights from Design Expert Software

  2025cites this paper
• The Associations Between Glaucoma and Circadian Rhythm Sleep Disorders in California Medicare Beneficiaries.

  2025cites this paper
• Challenge of Corneal Ulcer Healing: A Novel Conceptual Framework, the “Triad” of Corneal Ulcer Healing/Corneal Neovascularization/Intraocular Pressure, and Avascular Tendon Healing, for Evaluation of Corneal Ulcer Therapy, Therapy of Neovascularization, Glaucoma Therapy, and Pentadecapeptide BPC 157

  2025cites this paper
• Human nerve growth factor delivery to the retina: Quantitative methodology and mathematical modeling in preclinical settings

  2025cites this paper
• Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments.

  2024cites this paper
• Molecular pathways in experimental glaucoma models

  2024cites this paper
• Advances in Neuroprotection in Glaucoma: Pharmacological Strategies and Emerging Technologies

  2024cites this paper
• Topical Nerve Growth Factor (NGF) restores electrophysiological alterations in the Ins2Akita mouse model of diabetic retinopathy.

  2023cites this paper
• Future directions of glaucoma treatment: emerging gene, neuroprotection, nanomedicine, stem cell, and vascular therapies

  2023cites this paper
• The Role of Retinal Ganglion Cell Structure and Function in Glaucoma

  2023cites this paper
• Intravitreal Administration of rhNGF Enhances Regenerative Processes in a Zebrafish Model of Retinal Degeneration

  2022cites this paper
• Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art

  2022cites this paper
• Retinal Ganglion Cell Transplantation: Approaches for Overcoming Challenges to Functional Integration

  2021cites this paper
• Protection of retinal ganglion cells in glaucoma: Current status and future.

  2021cites this paper
• Investigational neuroprotective compounds in clinical trials for retinal disease

  2021cites this paper
• Phase 1b randomized controlled study of short course topical recombinant human nerve growth factor (rhNGF) for neuroenhancement in glaucoma: safety, tolerability and efficacy measure outcomes.

  2021cites this paper
• TGFβ-Neurotrophin Interactions in Heart, Retina, and Brain

  2021cites this paper
• The First and Last Time I Met Rita Levi-Montalcini: From the Insect Neurotrophic Factor to the Nerve Growth Factor Clinical Application : RLM and the Discovery of Two Neurotrophic Factors.

  2021cites this paper
• Multifactorial Pathogenic Processes of Retinal Ganglion Cell Degeneration in Glaucoma towards Multi-Target Strategies for Broader Treatment Effects

  2021cites this paper
• Nerve Growth Factor as an Ocular Therapy: Applications, Challenges, and Future Directions

  2021cites this paper
• Longitudinal outcomes of circumlimbal suture model-induced chronic ocular hypertension in Sprague-Dawley albino rats

  2020cites this paper
• Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration

  2020cites this paper
• Astragalus membranaceus Injection Protects Retinal Ganglion Cells by Regulating the Nerve Growth Factor Signaling Pathway in Experimental Rat Traumatic Optic Neuropathy

  2020cites this paper
• Localized co-delivery of CNTF and FK506 using a thermosensitive hydrogel for retina ganglion cells protection after traumatic optic nerve injury

  2020cites this paper
• Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead

  2020cites this paper
• Protect, Repair, and Regenerate: Towards Restoring Vision in Glaucoma

  2020cites this paper
• In vivo effects of single or combined topical neuroprotective and regenerative agents on degeneration of retinal ganglion cells in rat optic nerve crush model

  2019cites this paper
• High hydrostatic pressure induces apoptosis of retinal ganglion cells via regulation of the NGF signalling pathway

  2019cites this paper
• Effect of topical administration of the microneurotrophin BNN27 in the diabetic rat retina

  2019cites this paper
• Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications

  2019cites this paper
• Novel Therapeutic Targets for Glaucoma: Disease Modification Treatment, Neuroprotection, and Neuroregeneration

  2019cites this paper
• Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation

  2019cites this paper
• Nerve Growth Factor: Early Studies and Recent Clinical Trials

  2018cites this paper
• Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results

  2018cites this paper
• Nerve Growth Factor Role on Retinal Ganglion Cell Survival and Axon Regrowth: Effects of Ocular Administration in Experimental Model of Optic Nerve Injury

  2018cites this paper
• The Role of Endogenous Neuroprotective Mechanisms in the Prevention of Retinal Ganglion Cells Degeneration

  2018cites this paper
• Expression and signaling of NGF in the healthy and injured retina.

  2017cites this paper
• THEREOF FOR PREVENTING RETNAL DSORDERS

  2017cites this paper
• Targets of Neuroprotection in Glaucoma

  2017cites this paper
• Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress

  2017cites this paper
• Neuroprotective effects of a novel peptide, FK18, under oxygen‐glucose deprivation in SH‐SY5Y cells and retinal ischemia in rats via the Akt pathway

  2017cites this paper
• Effects of neuroactive agents on axonal growth and pathfinding of retinal ganglion cells generated from human stem cells

  2017cites this paper
• NGF/anti-VEGF combined exposure protects RCS retinal cells and photoreceptors that underwent a local worsening of inflammation

  2017cites this paper
• Neuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal Degeneration

  2016cites this paper
• Induction of hypoxia-inducible factor-1α by BDNF protects retinoblastoma cells against chemotherapy-induced apoptosis

  2016cites this paper
• Nerve growth factor protects retinal ganglion cells against injury induced by retinal ischemia–reperfusion in rats

  2015cites this paper
• Imbalance of the Nerve Growth Factor and Its Precursor: Implication in Diabetic Retinopathy

  2015cites this paper
• Cytidine 5′-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives

  2015cites this paper
• Neuroprotection in the treatment of glaucoma--A focus on connexin43 gap junction channel blockers.

  2015cites this paper
• Sustained intravitreal delivery of connexin43 mimetic peptide by poly(D,L-lactide-co-glycolide) acid micro- and nanoparticles--Closing the gap in retinal ischaemia.

  2015cites this paper
• Cell Adhesion Molecules

  2014cites this paper
• Nerve growth factor inhibits osmotic swelling of rat retinal glial (Müller) and bipolar cells by inducing glial cytokine release

  2014cites this paper
• Neural cell adhesion molecules belonging to the family of leucine-rich repeat proteins.

  2014cites this paper
• The Nerve Growth Factor Signaling and Its Potential as Therapeutic Target for Glaucoma

  2014cites this paper
• Development and Implementation of Multi-Cued Guidance Strategies for Axonal Regeneration

  2014cites this paper
• Translational models of ocular disease.

  2013cites this paper
• The molecular basis of retinal ganglion cell death in glaucoma.

  2012cites this paper
• Targeting reactive astrogliosis by novel biotechnological strategies.

  2012cites this paper
• Protecting the retinal neurons from glaucoma: lowering ocular pressure is not enough.

  2012cites this paper
• Protective Effects of 7,8-Dihydroxyflavone on Retinal Ganglion and RGC-5 Cells Against Excitotoxic and Oxidative Stress

  2012cites this paper
• Clinical and molecular genetic study of 12 Italian families with autosomal recessive Stargardt disease.

  2012cites this paper
• An investigation into pro-apoptotic targets in experimental glaucoma and the neuroprotective effects of Ginkgo biloba in retinal ganglion cells

  2012influential citation
• Rationale for the use of multifunctional drugs as neuroprotective agents for glaucoma

  2012cites this paper
• Neuroprotection in Glaucoma

  2011cites this paper
• Rats! Hyperglycemia protects against glaucoma!

  2011cites this paper
• Time-Dependent Activation of c-fos in Limbic Brain Areas by Ocular Administration of Nerve Growth Factor in Adult Rats

  2011cites this paper
• The nerve growth factor administrated as eye drops activates mature and precursor cells in subventricular zone of adult rats.

  2011cites this paper
• Clinical applications of NGF in ocular diseases.

  2011cites this paper
• Neuroprotection in glaucoma - Is there a future role?

  2010influential citation